Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (2465)	1/15/1999 4:23:00 PM
From: BWAC	Respond to of 2553

I would like to see what the SG Cowen analyst report looks like. Anybody have access to this?

To: Machaon who wrote (2465)	1/16/1999 1:11:00 PM
From: ajs	Read Replies (1) \| Respond to of 2553

I read in today's sport page, "Rochester, N.Y. D&C", a small article titled " Dead Man livens up soccer star's knee" A German soccer player, hopes to revive his career after having the knee tissue of a dead man transplanted into his knee. Christian Wueck, 25 received the tissue from a 50 year old man.- he was quoted as saying this was the only way for him to resume his career, an examination 1/21/99 will determine if it was a success. - As stockholder in Genzl I could not help but think that Carticle could have been option. Am I correct? In the conference call I believe Genzl will be marketing to athletes, a few high profile running backs in the NFL as successful patients would do wonders for marketing! Any comments? Is this feasible?